Papp, K.A., Merola, J.F., Gottlieb, A.B., Griffiths, C.E., Harris, K.K., Cross, N., Peterson, L., Cioffi, C. and Blauvelt, A. 2019. Bimekizumab provides rapid and sustained improvements in quality of life that correlate with clinical outcomes in patients with moderate to severe plaque psoriasis: 60 week results from a randomized , double blinded , Phase 2b extension study. SKIN The Journal of Cutaneous Medicine. 3, (Nov. 2019), S35. DOI:https://doi.org/10.25251/skin.3.supp.35.